ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,929Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 890

$1.68M Total Retail Price of All Prescriptions

Rank: 4 out of 890

863 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 863 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

17% of this provider’s 863 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 20,889 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
AMLODIPINE BESYLATE 1,196 1,001 1 1
LEVOTHYROXINE SODIUM 780 547 2 2
SIMVASTATIN 643 508 3 5
LISINOPRIL 639 497 4 4
FUROSEMIDE 614 496 5 7
METOPROLOL SUCCINATE 523 390 6 17
ATORVASTATIN CALCIUM 512 377 7 13
RAMIPRIL 498 331 8 80
METFORMIN HCL 488 386 9 6
HYDROCODONE-ACETAMINOPHEN 483 352 S3 10 3
HYDROCHLOROTHIAZIDE 459 394 11 9
GABAPENTIN 425 331 12 12
METFORMIN HCL ER 420 329 13 54
NEXIUM 414 319 14 14
OMEPRAZOLE 407 287 15 8
METOPROLOL TARTRATE 391 340 16 15
POTASSIUM CHLORIDE 335 280 17 11
FLUTICASONE PROPIONATE 331 265 18 39
ADVAIR DISKUS 295 219 19 52
CRESTOR 292 193 20 25
ZOLPIDEM TARTRATE 280 183 21 19
TAMSULOSIN HCL 256 188 22 32
CITALOPRAM HBR 254 195 23 20
PANTOPRAZOLE SODIUM 250 190 24 34
PRAVASTATIN SODIUM 247 204 25 10
LOSARTAN POTASSIUM 242 225 26 29
VENLAFAXINE HCL ER 242 213 26 114
SPIRIVA 238 192 28 66
CLOPIDOGREL 229 219 29 28
ALENDRONATE SODIUM 224 193 30 38
NAMENDA 221 221 31 36
ROPINIROLE HCL 219 194 32 93
WARFARIN SODIUM 211 183 33 24
ALLOPURINOL 209 182 34 31
TRAZODONE HCL 201 166 35 40
SERTRALINE HCL 198 140 36 26
ESCITALOPRAM OXALATE 197 120 37 51
MELOXICAM 193 112 38 18
DONEPEZIL HCL 186 184 39 30
TRAMADOL HCL 178 135 40 16
SYNTHROID 178 125 40 53
ATENOLOL 178 166 40 23
DIOVAN 178 138 40 33
CYMBALTA 176 94 44 45
ISOSORBIDE MONONITRATE ER 155 125 45 60
IBUPROFEN 151 117 46 101
CIPROFLOXACIN HCL 139 109 47 58
AMLODIPINE BESYLATE-BENAZEPRIL 135 116 48 41
TRIAMTERENE-HCTZ 134 87 49 61
BENAZEPRIL HCL 131 101 50 44
LIPITOR 130 100 51 77
ACTOS 128 81 52 88
PLAVIX 127 122 53 42
ALPRAZOLAM 119 109 54 95
MEGESTROL ACETATE 117 114 R 55 92
LOSARTAN-HYDROCHLOROTHIAZIDE 113 85 56 57
FLUOXETINE HCL 107 81 57 63
PRAMIPEXOLE DIHYDROCHLORIDE 107 86 57 175
QUETIAPINE FUMARATE 103 71 59 73
RANITIDINE HCL 103 75 59 49
AZITHROMYCIN 101 64 61 37
AVODART 99 74 62 198
LANTUS 94 77 63 50
FENOFIBRATE 94 72 63 74
FINASTERIDE 93 75 65 108
GLIPIZIDE ER 93 72 65 110
PROAIR HFA 93 73 65 55
PREDNISONE 91 70 68 47
KLOR-CON M20 91 85 68 72
JANUVIA 88 67 70 59
TEKTURNA 87 81 71 247
CARBIDOPA-LEVODOPA 87 78 71 136
AGGRENOX 86 78 73 219
AMITRIPTYLINE HCL 84 64 R 74 43
LANTUS SOLOSTAR 83 58 75 102
AMOX TR-POTASSIUM CLAVULANATE 82 62 76 132
INSULIN SYRINGE 80 50 77 99
LEVETIRACETAM 79 38 78 137
ESTRADIOL 77 59 R 79 118
PROPRANOLOL HCL 76 67 80 141
LYRICA 76 41 80 71
LISINOPRIL-HYDROCHLOROTHIAZIDE 74 42 82 21
TOPIRAMATE 71 28 83 245
EXFORGE 70 45 84 140
POLYETHYLENE GLYCOL 3350 68 49 85 67
METOCLOPRAMIDE HCL 68 48 85 125
LEVOCETIRIZINE DIHYDROCHLORIDE 68 61 85 131
DIOVAN HCT 67 55 88 48
LEXAPRO 66 40 89 186
VERAPAMIL ER 65 52 90 87
PAROXETINE HCL 64 45 91 68
NYSTATIN 64 59 91 173
CLONIDINE HCL 62 30 93 35
NITROFURANTOIN MONO-MACRO 61 58 94 181
FAMOTIDINE 61 61 94 90
HYDRALAZINE HCL 61 44 94 100
NIFEDIPINE ER 61 61 94 75
DIVALPROEX SODIUM ER 60 25 98 192
CARVEDILOL 58 46 99 22
SYMBICORT 58 49 99 174
PRISTIQ ER 57 31 101 267
MUPIROCIN 57 49 101 121
DOXAZOSIN MESYLATE 56 48 103 70
MIRTAZAPINE 56 53 103 82
NASONEX 55 42 105 170
ZETIA 55 54 105 81
SPIRONOLACTONE 55 25 105 85
PEN NEEDLE 55 42 105 135
DETROL LA 53 53 109 164
QUINAPRIL HCL 53 41 109 116
EXELON 52 52 111 113
ABILIFY 52 24 111 172
EVISTA 52 52 111 182
TIZANIDINE HCL 51 28 114 106
LOVAZA 51 40 114 120
XOPENEX HFA 51 26 114 348
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 7, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.